JULIE LEFFLER: Open Payments
NPI 1750855425 · MILWAUKIE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 75 payments from 22 companies in 2025. Trend: 2023 $1,660 · 2024 $1,867 · 2025 $1,645
Food & beverage: $1,645
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $277 |
| ABBVIE INC. | 12 | $185 |
| Aimmune Therapeutics, Inc. | 7 | $176 |
| Otsuka America Pharmaceutical, Inc. | 14 | $175 |
| Novo Nordisk Inc | 7 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $96 |
| Exact Sciences Corporation | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 2 | $71 |
| Corcept Therapeutics | 2 | $51 |
| Lundbeck LLC | 2 | $50 |
Products named: REXULTI, BREZTRI, ZENPEP, Kerendia, AIRSUPRA, VRAYLAR, The Cologuard Plus Collection Kit, AUSTEDO XR.
Industry payments across OR — which companies pay providers there.
